| (USD) | Sep 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.40M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZVSA returned -25.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -23.1% |
| 1 year | -25.9% |
| All-time high | $3,556.00 (Nov 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ZVSA would be worth today ›No. ZyVersa Therapeutics, Inc. has not paid a dividend in the past 12 months.
ZyVersa Therapeutics, Inc. is part of the Healthcare sector.
ZyVersa Therapeutics, Inc. has a market cap of 833.88K USD, based on the latest quote.
ZyVersa Therapeutics, Inc. is expected to report earnings around Aug 24, 2026. That date is an estimate and has not been confirmed by the company.